[...] Mentorship is about the mentee, not the mentor. The mentor may receive immense satisfaction from nurturing the mentee’s development [...] but that satisfaction is secondary to the benefit the mentee receives.
DOI: 10.1056/NEJMp2313304
A reflection on oncology, literature, an the ways books can accompany patients and doctors through illness and hospital life. 📚📖 https://t.co/WtC2VKLPyJ
📌 Our data (LEA study) - just published by EJC - are the new backbone to assess prognostic performance and timing of plasma EBV-DNA in curable non-endemic NPC!
https://t.co/5mAEgSEiMn
Excited to share our new review on the Management of Testicular Cancer just out in @JCOOP_ASCO ! A practical overview on diagnosis, treatment, and survivorship. @robert_huddart Alison Reid @WalterCazzaniga@DeepOnco@OncoAlert
Check it out here: https://t.co/9UQh5uwpgd
"[...] In 2022, Italy spent €1.8 billion on digital healthcare, a 7% increase from the previous year. However, it remains unclear whether these funds have been fully utilised and how they were spent [...]"
https://t.co/WVzbFxRqUA
🎉 We just celebrated our 1st birthday with an amazing #LabRetreat at Lago Maggiore ! A very full day to recap 2024 and plan for 2025 in #radiomics, digital pathology, #LLMs, bioinformatics, AI applied to multi-omics ... our now 20+ members feel barely enough !
Stay tuned !! 😉
💥«Il Sud muore». Una malattia che sento denunciata da quando sono ragazzino, dai primi anni Zero. Un'agonia lenta e diffusa che vent'anni dopo è addirittura peggiorata, che ne corrode la fibra economica, sociale, democratica. Con una differenza: non interessa più nessuno.
🧵
1/
Ad #AIOMGiovani 2024 si è tenuta una Sessione speciale dedicata all’Oncologia nei contesti di guerra, moderata da @MassimoDiMaio75 e @darioT_.
Sono intervenuti Veronika Patsko, @FroitbergM e Ettore Mazzanti. Ce ne parla su #AIOMTv, Dario Trapani: https://t.co/1PrTGRxkDh
Smashing out day 1 of #aiomgiovani annual meeting: so many brilliant presentations in a wonderful location! And of course, sharing it with good old friends
@AIOMtweet@AiomFondazione
A regimen of nab-paclitaxel, cisplatin, and capecitabine showed a superior antitumoural efficacy and favourable safety profile compared with gemcitabine and cisplatin for nasopharyngeal carcinoma, finds study.
#VisualAbstract
Study 🔗 https://t.co/3IpACl4mEW
Just out in @ESMO_Open our large experience exploring prognostic signature of patients with astrocytoma IDHm G4‼️🤩
Shedding some light on this “grey-zone” entity between IDHm and IDHwt gliomas! 🔦🧠
@EANOassociation
https://t.co/EAXiUpsWMh
I’ve scrolled and scrolled. None of the 3 major papers in Italy has a single line in their homepage of what is happening in #Georgia.
What exactly is newsworthy to you @corriere@repubblica@LaStampa?
Unbelievable.
Combining RWD and genomics from liquid biopsy for ML prediction of prognosis in NSCLC at poster presentation of 2nd Italian conference on AI for oncology chaired by @PrelajArsela
"I go to my fathers. And even in their mighty company I shall not now be ashamed. I felled the black serpent. A grim morn, and a glad day, and a golden sunset!"
" [...] Perché c’è un solo modo per rendere l’idea di convivenza qualcosa di realistico e politicamente efficace: chiederla insieme".
https://t.co/7ceNOAcGNf